Published in Prostate on May 01, 2003
The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res (2008) 2.29
MYC and Prostate Cancer. Genes Cancer (2010) 1.54
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer (2005) 1.46
mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Exp Mol Pathol (2009) 1.17
NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol (2010) 0.97
TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells. Cancer Cell Int (2013) 0.84
NKX3.1 expression is lost in testicular germ cell tumors. Am J Pathol (2003) 0.79
Hydroxymethylation is uniquely distributed within term placenta, and is associated with gene expression. FASEB J (2016) 0.79
Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner. J Biol Chem (2012) 0.78
The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation. Mol Cancer (2005) 0.77
Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer? Nephrourol Mon (2016) 0.75
NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. J Clin Pathol (2014) 0.75
Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma. J Pathol Transl Med (2016) 0.75
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat Genet (2004) 2.44
Patterns of pulmonary complications associated with sirolimus. Respiration (2005) 2.20
Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol (2010) 2.16
Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol (2004) 2.04
Stat3 promotes metastatic progression of prostate cancer. Am J Pathol (2008) 1.85
Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res (2003) 1.83
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer (2011) 1.62
A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer (2002) 1.60
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res (2002) 1.58
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease. Endocr Relat Cancer (2013) 1.57
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. Lancet Oncol (2012) 1.54
Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A (2011) 1.47
HER2 gene status in primary breast cancers and matched distant metastases. Breast Cancer Res (2007) 1.45
Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols. Urology (2013) 1.39
EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. Virchows Arch (2012) 1.34
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor. Mod Pathol (2010) 1.33
Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clin Cancer Res (2005) 1.26
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate (2003) 1.26
Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PLoS One (2012) 1.26
Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Mol Endocrinol (2002) 1.22
ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol Endocrinol (2011) 1.21
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Res (2008) 1.21
Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer (2005) 1.20
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology (2007) 1.19
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer (2010) 1.16
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer (2006) 1.15
Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res (2007) 1.15
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am J Pathol (2010) 1.11
ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J Cell Physiol (2006) 1.11
Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone. J Thorac Oncol (2013) 1.09
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer (2007) 1.08
Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia (2002) 1.07
Deep clonal profiling of formalin fixed paraffin embedded clinical samples. PLoS One (2012) 1.03
Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer. Am J Respir Crit Care Med (2009) 1.02
Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res (2008) 1.02
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Int J Cancer (2009) 1.00
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. Int J Cancer (2009) 1.00
Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clin Cancer Res (2013) 0.99
Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria. J Thorac Oncol (2014) 0.98
Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. Clin Cancer Res (2004) 0.97
Role of KCNMA1 in breast cancer. PLoS One (2012) 0.94
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer. Hum Pathol (2011) 0.94
ANXA7 expression represents hormone-relevant tumor suppression in different cancers. Int J Cancer (2007) 0.94
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. Eur J Cancer (2012) 0.94
Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J Transl Med (2011) 0.94
Urine cytology findings of polyomavirus infections. Adv Exp Med Biol (2006) 0.93
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer (2012) 0.92
Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant (2008) 0.91
An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. Am J Clin Pathol (2006) 0.90
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Rev Anticancer Ther (2013) 0.89
Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. J Thorac Oncol (2014) 0.89
Physical and transcript map of the hereditary prostate cancer region at xq27. Genomics (2002) 0.88
Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation. Mod Pathol (2007) 0.87
Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice. Prostate (2015) 0.87
Abundant expression of AMACR in many distinct tumour types. Pathology (2006) 0.86
Aspergillus sellar abscess: case report and review of the literature. Neurol India (2008) 0.86
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. Eur J Cancer (2008) 0.86
Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer. J Clin Pathol (2006) 0.86
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer. J Pathol (2011) 0.86
Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature. Arch Pathol Lab Med (2004) 0.86
Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens. Lung Cancer (2009) 0.85
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. Prostate (2012) 0.85
Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer. Hum Pathol (2013) 0.85
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells. Mol Endocrinol (2008) 0.85
PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer. Am J Pathol (2012) 0.84
STAT5A/B gene locus undergoes amplification during human prostate cancer progression. Am J Pathol (2013) 0.84
Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm. Chest (2005) 0.84
Role of fluorescence in situ hybridization in lung cancer cytology. Acta Cytol (2012) 0.84
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07). Clin Cancer Res (2012) 0.83
Lung resection in hematologic patients with pulmonary invasive fungal disease. Chest (2012) 0.83
Application of personalized medicine to solid tumors: opportunities and challenges. Swiss Med Wkly (2012) 0.83
DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine. Cancer (2002) 0.83
Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology. Chest (2006) 0.82
Progressive pulmonary sarcoidosis--a fibroproliferative process potentially triggered by EGR-1 and IL-6. Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.82
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia. J Virol (2012) 0.82
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer. Int J Cancer (2013) 0.82
Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues. Pathology (2006) 0.82
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer. PLoS One (2013) 0.82
Treatment and detection of ALK-rearranged NSCLC. Lung Cancer (2013) 0.82
Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest (2010) 0.82
Montelukast and Churg-Strauss syndrome. Swiss Med Wkly (2004) 0.81
Morphological spot counting from stacked images for automated analysis of gene copy numbers by fluorescence in situ hybridization. J Biomed Opt (2002) 0.81
Clonal evolution and therapeutic resistance in solid tumors. Front Pharmacol (2013) 0.81
HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study. Mod Pathol (2013) 0.81
Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis. Respir Med (2007) 0.79
Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I. Biochem J (2013) 0.79
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2013) 0.78
ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer. Virchows Arch (2012) 0.78
Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology. Cancer Cytopathol (2011) 0.77
Tissue microarrays meet cytopathology. Acta Cytol (2006) 0.77
Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC. Cancer Cytopathol (2013) 0.77
Genomic analysis and selected molecular pathways in rare cancers. Phys Biol (2012) 0.76
Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia? Hum Pathol (2011) 0.76
Anaplastic lymphoma kinase 1 detected by immunohistochemistry in non-small cell lung cancer: a promising feature? Hum Pathol (2010) 0.75
Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer. Eur Urol (2007) 0.75
An unexpected cause of diffuse alveolar hemorrhage in a kidney transplant patient. Respiration (2014) 0.75
Dysplastic cells in cytological cervical samples show a high incidence of chromosomal abnormalities. Diagn Cytopathol (2010) 0.75
Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy. Virchows Arch (2014) 0.75
Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology. Cancer Cytopathol (2014) 0.75